drugset / Trial / NCT02183051
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the analgesic efficacy and tolerability of meloxicam 15 mg, 7.5 mg, 3.75 mg and 1.875 mg oral (rapid release tablet) compared with placebo and ibuprofen 400 mg and 200 mg administered in a single dose, over an observation period of 6 hours in the treatment of pain after surgery of the third molar.
Timeline
- Start
- 1998-04
- Primary completion
- 1998-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ibuprofen | Small molecule | 200 mg | Oral |
| Comparator | Ibuprofen | Small molecule | 400 mg | Oral |
| Subject | Meloxicam | Small molecule | 1.875 mg | Oral |
| Subject | Meloxicam | Small molecule | 3.75 mg | Oral |
| Subject | Meloxicam | Small molecule | 7.5 mg | Oral |
| Subject | Meloxicam | Small molecule | 15 mg | Oral |
Indications
No indication recorded.